Product Description
Brand Acon
Sample Type Serum/ Plasma/ WB
Pack Size 25T
CAT No F131-40611
Biomarker Cardiac
The cTnI/CK-MB/Myo FIA Test is a fluorescence immunoassay that is used with the FIAflex Fluorescent Immunoassay Analyzer for the quantitative detection of cTnI, CK-MB and myoglobin in human serum, plasma and venous whole blood. It is useful as an aid in management and monitoring of acute myocardial infarction (AMI).
Comprehensive Cardiac Marker DetectionThis test kit enables simultaneous quantification of cardiac Troponin I, CK-MB, and Myoglobin-important biomarkers for diagnosing myocardial infarction and other cardiac events. By offering a broad measurement range for each analyte, it supports comprehensive cardiac evaluations.
Rapid and Accurate ResultsBenefit from fast turnaround times; results are available within 15 minutes, facilitating timely clinical decisions. The advanced fluorescent immunoassay technology ensures high sensitivity and specificity, crucial for accurate cardiac assessments in acute care situations.
Effortless and Reliable OperationDesigned for professional laboratory use, the system is fully automatic and requires minimal training. Test cassettes are lightweight, easy to handle, and present results digitally when used with the FIAflex Analyzer, streamlining workflow and enhancing efficiency.
FAQ's of Acon FIAflex cTnI/CK-MB/Myo FIA Test:
Q: How is the Acon FIAflex cTnI/CK-MB/Myo FIA Test performed?
A: To perform the test, collect whole blood, serum, or plasma (typically 100 L), add it to the provided test cassette along with buffer, and insert the cassette into the compatible FIAflex Analyzer. Results are generated automatically within 15 minutes.
Q: What are the primary benefits of using this test kit for cardiac assessment?
A: The kit offers high sensitivity and specificity for cardiac biomarkers, delivers results quickly (in 15 minutes), and supports both qualitative and quantitative analysis. It contributes to prompt clinical decision-making, especially in acute cardiac settings.
Q: When should this test be used in a clinical setting?
A: This test is recommended for use when cardiac markers need to be evaluated, such as during suspected myocardial infarction or acute chest pain episodes, to support rapid diagnosis and treatment decisions.
Q: Where is the Acon FIAflex test intended to be used?
A: The test is intended for professional use in laboratory environments. It is not designed for self-testing or point-of-care use by untrained personnel, ensuring accuracy and reliability in clinical diagnostics.
Q: What cardiac biomarkers does the kit detect, and what is their clinical significance?
A: The kit detects cardiac Troponin I (cTnI), Creatine Kinase-MB (CK-MB), and Myoglobin, all of which are important in diagnosing heart muscle injury and assessing the severity and timing of cardiac events.
Q: How should the test components be stored to maintain integrity?
A: Store all kit components between 2C to 30C and protect them from direct sunlight to preserve their shelf life and analytical performance.